US Patent Issued to The University of Hong Kong on Sept. 23 for "Fecal microbial biomarkers for non-alcoholic fatty liver disease" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,562, issued on Sept. 23, was assigned to The University of Hong Kong (Hong Kong).

"Fecal microbial biomarkers for non-alcoholic fatty liver disease" was invented by Hein Min Tun (Hong Kong), Sai Sai Zhang (Hong Kong), Hau Tak Chau (Hong Kong), Fung Yu Huang (Hong Kong), Man Fung Yuen (Hong Kong) and Wai Kay Seto (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are microbial biomarkers and methods for accurate non-invasive diagnosis of non-alcoholic fatty liver disease (NAFLD) in subjects. The microbial biomarkers include Lactococcus lactis as well as its strains and subspecies. The microbial biomarkers include Dorea sp. 5-2. The ...